Munro APS, Feng S, Janani L, Cornelius V, et al. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomis Lancet Infect Dis 2022 May 9. pii: S1473-3099(22)00271.
PMID: 35550261